The MRI contrast developer formerly known as Advanced Magnetics has changed its name to AMAG Pharmaceuticals.
The Cambridge, MA, firm said it made the change to capture "the exciting opportunities" that lie ahead of the firm. AMAG markets the MRI contrast agents Feridex I.V. and GastroMark, and has two products in development -- Combidex, an MRI contrast agent for lymph node use, and ferumoxytol, an iron-replacement therapy.
By AuntMinnie.com staff writers
July 26, 2007
Related Reading
Advanced Magnetics proposes stock offering, May 17, 2007
Advanced Magnetics names Arkowitz as CFO, April 6, 2007
Goldstein to retire from Advanced Magnetics, April 3, 2007
Advanced Magnetics shuffles execs, November 9, 2006
Advanced Magnetics adds execs, September 11, 2006
Copyright © 2007 AuntMinnie.com